Piretanide
Product Specifications
UNSPSC Description
Piretanide is an oral active, relatively safe and effective diuretic. Piretanide has the potential for the research of congestive heart failure with a potential advantage of having potassium-sparing properties. Piretanide can also be used for the research of hypertension[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/piretanide.html
Purity
99.87
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(S(=O)(N)=O)=C(C(N2CCCC2)=C1)OC3=CC=CC=C3)O
Molecular Weight
362.40
References & Citations
[1]Carda-Broch S, et al. Analysis of urine samples containing cardiovascular drugs by micellar liquid chromatography with fluorimetric detection. J Chromatogr Sci. 1999;37(4):93-102. |[2]Sherman LG, et al. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. Clin Pharmacol Ther. 1986;40(5):587-594.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119816/Piretanide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119816/Piretanide-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
55837-27-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal TRP7 Antibody (S64A-36) [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/genprice3.png)
NBP1-48318JF549 0.1 mL
Mouse Monoclonal TRP7 Antibody (S64A-36) [Janelia Fluor 549]
Ask
View Details OR1048009-01 100 mg
N-Benzhydryl-2- ((2,5-dichloro-N-methylphenyl) sulfonamido) acetamide
Ask
View Details 
OR1048009-02 250 mg
N-Benzhydryl-2- ((2,5-dichloro-N-methylphenyl) sulfonamido) acetamide
Ask
View Details 
OR1048009-03 1 g
N-Benzhydryl-2- ((2,5-dichloro-N-methylphenyl) sulfonamido) acetamide
Ask
View Details 